Casirivimab
Product Specifications
CAS Number
2415933-42-3
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
Casirivimab (REGN10933), a human monoclonal antibody targeting the SARS-CoV-2 virus responsible for COVID-19, demonstrates reduced efficacy against emerging variants. When combined with Imdevimab, it significantly lowers viral load and enhances disease outcomes [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2037803-01 0.1 mL
PE-Linked Polyclonal Antibody to Matrix Metalloproteinase 3 (MMP3)
Ask
View Details 
MBS2037803-02 0.2 mL
PE-Linked Polyclonal Antibody to Matrix Metalloproteinase 3 (MMP3)
Ask
View Details MBS2037803-03 0.5 mL
PE-Linked Polyclonal Antibody to Matrix Metalloproteinase 3 (MMP3)
Ask
View Details 
MBS2037803-04 1 mL
PE-Linked Polyclonal Antibody to Matrix Metalloproteinase 3 (MMP3)
Ask
View Details MBS2037803-05 5 mL
PE-Linked Polyclonal Antibody to Matrix Metalloproteinase 3 (MMP3)
Ask
View Details MBS2037803-06 5x 5 mL
PE-Linked Polyclonal Antibody to Matrix Metalloproteinase 3 (MMP3)
Ask
View Details